Merichem Technologies’ Product Safety Summary: LO-CAT® Catalysts
Merichem Technologies used ACC’s Prioritization Screening Approach to conduct an Initial Screening of its LO-CAT™ Catalyst Products. Data from each product’s GHS SDS was used to complete the Environmental Ranking and Human Health Ranking, then we determined the product’s use pattern (Use), production volume (Tonnage), and whether the product is persistent or bioaccumulative (PB). The sum of the Exposure Rankings (Use + PB + Tonnage) was plotted to the Hazard Rankings to determine the Risk Scale.
| Priority Grouping = Hazard + Exposure Ratings | Exposure Ranking = Sum (Use + PB + Tonnage) | ||||||
| Hazard Ranking (Higher Score from Environmental and Human Health Hazards | 3-4 | 5-6 | 7-8 | 9-10 | 11-13 | ||
| Low | Med-Low | Medium | Med-High | High | |||
| Environmental Hazard | Human Health Hazard | 1 | 2 | 3 | 4 | 5 | |
| Low | Not Classified | Not carcinogen/mutagen/repro/develop; OR Repeat Dose >1000 mg/kg/day (oral); > 2000 mg/kg/day (dermal); > 1000 ppm/6hr/day (gas inhalation); >5.0 mg/l/6h/day (vapour inhalation); > 1.0 mg/l/6h/day (dust mist fume inhal). | |||||
| Medium | Acute III or Chronic III/IV or none | Not carcinogen/mutagen/repro/develop; OR Repeat Dose 100 - 1000 mg/kg/day (oral); 200 - 2000 mg/kg/day (dermal); 250 - 1000 ppm/6hr/day (gas inhalation); 1.0 - 5.0 mg/l/6h/day (vapour inhalation); 0.2 - 1.0 mg/l/6h/day (dust mist fume inhal). | |||||
| Medium High | Acute II or Chronic II | GHS CMR Cat 2; OR Repeat Dose 10 - 100 mg/kg/day (oral); 20 - 200 mg/kg/day (dermal); 50 - 250 ppm/6hr/day (gas inhalation); 0.2 - 1.0 mg/l/6h/day (vapour inhalation); 0.02 - 0.2 mg/l/6h/day (dust mist fume inhal). | |||||
| High | Acute I or Chronic I or Insufficient Information to Classify | GHS CMR Cat 1a, 1b; OR Repeat Dose |
|
||||
The following Product Safety Summaries are high-level and intended to provide the public with an overview of product safety information on these chemical products. It is not intended to provide emergency response, medical or treatment information, or to provide an overview of all safety and health information. This summary is not intended to replace the Safety Data Sheet. For detailed guidance on the use or regulatory status of this substance, please consult the Safety Data Sheet.